Question 1

Does Lido Advisors own RLMD stock?

Accepted Answer

Yes. As of its Q3 2026 13F, Lido Advisors holds 13,827 shares of RLMD (Relmada Therapeutics), worth $52,128.

Question 2

How many shares of RLMD does Lido Advisors own?

Accepted Answer

As of its Q3 2026 13F, Lido Advisors holds 13,827 shares of RLMD (Relmada Therapeutics).

Question 3

What is Lido Advisors' RLMD position worth?

Accepted Answer

As of its Q3 2026 13F, Lido Advisors' RLMD position is worth $52,128.

Question 4

Is Lido Advisors buying or selling RLMD?

Accepted Answer

In Q3 2026, Lido Advisors reduced its RLMD position by 78 shares (-0.6%).

Question 5

When did Lido Advisors first buy RLMD?

Accepted Answer

Lido Advisors first reported RLMD in its Q1 2025 13F and has listed it in 7 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Decreased	13,827	-0.6%	$52,128	0.0%	$3.77	0
2026-Q2	Unchanged	13,905	0.0%	$96,223	0.0%	$6.92	0
2026-Q1	Unchanged	13,905	0.0%	$96,779	0.0%	$6.96	0
2025-Q4	Unchanged	13,905	0.0%	$27,949	0.0%	$4.83	0
2025-Q3	Unchanged	13,905	0.0%	$27,949	0.0%	$2.01	0
2025-Q2	Unchanged	13,905	0.0%	$8,347	0.0%	$0.60	0
2025-Q1	New	13,905	—	$3,754	0.0%	$0.27	21